ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

In Brief: George Burton Retires After 23 Years At NCI; MDA Names Bodey Head Of Medical Specialists

February 20, 1987

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

April 22, 1994

National Coalition An Education Group, Chairman Says

May 3, 1985

Obituary: Sir Richard Doll, 92, epidemiologist who linked smoking to lung cancer.

July 29, 2005

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986